arXiv:2605. 25050v2 Announce Type: replace-cross Abstract: Integrating multimodal datasets in clinical oncology is frequently hindered by high dimensionality and blockwise missingness, where entire data sources are unavailable for specific patient subsets.
By Mohamed Boussena, Florence Monville, Jacques Fieschi-Meric, Frederic Vely, Pierre Milpied, Julien Mazieres, Maurice Perol, Eric Vivier, Laurent Greillier, Fabrice Barlesi, Sebastien Benzekry
arXiv:2607. 11656v1 Announce Type: cross Abstract: Accurate diagnostic classification and disease-severity prediction for Alzheimer's disease are hampered by the incompleteness and heterogeneity of real-world clinical data.
By Christelle Schneuwly Diaz, Narmina Baghirova, Duy-Thanh Vu, Duy-Cat Can, Gilles Allali, Philippe Ryvlin, Oliver Y. Ch\'en
arXiv:2606. 11144v1 Announce Type: new Abstract: Resistance to first-line osimertinib in EGFR-mutant non-small-cell lung cancer (NSCLC) is the canonical example of predictable clonal evolution under therapeutic pressure, yet no public benchmark exists for training or evaluating computational models on the corresponding longitudinal patient trajectories.
By Abhijoy Sarkar, Aarchi Singh Thakur
arXiv:2608. 16594v1 Announce Type: new Abstract: Cancer survival prediction supports treatment planning, risk stratification, and follow-up management.
By Tianqi Xiang, Qixiang Zhang, Xinpeng Ding, Yi Li, Xiaomeng Li
arXiv:2607. 09165v1 Announce Type: cross Abstract: Achieving early and timely diagnosis and treatment for disease is a major challenge.
By Qingchu Jin, Felistas Mazhude, Jamie B. Rabb, Robert S. Kramer, Douglas B. Sawyer, Raimond L. Winslow
arXiv:2607. 16802v1 Announce Type: new Abstract: Deep survival models are evaluated almost exclusively by the concordance index (C-index), yet they are commonly trained using likelihood objectives such as the Cox partial likelihood, discrete-time negative log-likelihood, and DeepHit likelihood.
By Meixu Chen, Kai Wang, Jing Wang
arXiv:2512. 13003v2 Announce Type: replace-cross Abstract: Out-of-distribution (OOD) detection is essential for determining when a supervised model encounters inputs that differ meaningfully from its training distribution.
By Min Lu, Hemant Ishwaran
arXiv:2606. 12006v1 Announce Type: cross Abstract: Predicting time-to-event outcomes such as mortality is a fundamental task in clinical decision-making, commonly addressed through survival analysis.
By Minh-Khoi Pham, Luca Cotugno, Alina Sirbu, Tai Tan Mai, Martin Crane, Marija Bezbradica
arXiv:2608. 04046v1 Announce Type: cross Abstract: Survival analysis is an established framework for analyzing time-to-event data, yet many clinical machine learning studies still binarize the outcome before model training.
By Shashank Yadav, David M. Routman, Andrew Y. K. Foong
arXiv:2607. 05613v1 Announce Type: new Abstract: Clinical care often relies on key laboratory indicators, yet real-world patient visits are sparse and tests are ordered irregularly, leading to pervasive missingness.
By Xinrui He, Mengting Ai, Junting Wang, Curtiss B. Cook, Jingrui He
arXiv:2607. 09521v1 Announce Type: new Abstract: Does every cancer patient truly need a complete diagnostic workup for accurate survival prediction?
By Chongyu Qu, Can Cui, Zhengyi Lu, Junchao Zhu, Tianyuan Yao, Junlin Guo, Juming Xiong, Yanfan Zhu, Yuechen Yang, Bennett A. Landman, Yuankai Huo
arXiv:2606. 29949v1 Announce Type: cross Abstract: H&E-stained whole-slide images offer cohort-scale availability and rich spatial context but lack molecular specificity, whereas bulk RNA-seq provides transcriptome-wide resolution at high cost with limited archival availability.
By Dominik Winter, Dominik Vonficht, Lo\"ic Le Bescond, Christian Gebbe, Marco Rosati, Richard J. Chen, Markus Schick, Ross Stewart, Nicolas Brieu